Assessing the risk of cognitive impairment among men with prostate cancer

Clin Adv Hematol Oncol. 2019 Nov;17(11):607-609.
No abstract available

Publication types

  • Interview

MeSH terms

  • Aged
  • Androgen Receptor Antagonists / adverse effects*
  • Cognitive Dysfunction / chemically induced*
  • Humans
  • Male
  • Middle Aged
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / psychology
  • Risk Factors

Substances

  • Androgen Receptor Antagonists